Kenji Hamase

This inventor holds 10 USPTO granted patents and 10 published patent applications and 5 EPO patents. Top assignees: Shiseido Company, Limited, Kyushu University, Kagami Inc.. Active years: 2013-2025.

USPTO Granted Patents = 10 (Patent Applications = 10)

% Patents Active = 40.0

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 3.9

ph-index = 1

Company Filing History:

6 out of 1,037

Shiseido Company, Limited

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12220394 - Pharmaceutical composition for prevention or treatment of kidney damage (2025-02-11),

2. 11099191 - Kidney disease prognosis prediction method and system (2021-08-24),

3. 10852308 - Disease-state biomarker for renal disease (2020-12-01),

4. 10753911 - Chiral analysis method of bound amino acid and chiral analysis system (2020-08-25),

5. 10393749 - Marker for early diagnosis of kidney failure (2019-08-27),

6. 9656948 - Compound, optical resolution method, and derivative of an optical isomer of an amino acid (2017-05-23),

7. 9266826 - Separating agent and manufacturing method thereof (2016-02-23),

8. 9193684 - Compound, optical resolution method, and derivative of an optical isomer of an amino acid (2015-11-24),

9. 9080995 - Method for quantitatively analyzing cysteine and cystine and reagent kit for quantitatively analyzing cysteine and cystine (2015-07-14),

10. 8592642 - Evaluation/screening method for diseases associated with D-amino acid utilizing DAO1-/-mouse (2013-11-26),

Title: Kenji Hamase: Innovator in Kidney Disease Treatment

Introduction

Kenji Hamase is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceutical compositions aimed at preventing and treating kidney diseases. With a total of 10 patents to his name, Hamase's work is recognized for its innovative approaches to kidney health.

Latest Patents

One of his latest patents is a pharmaceutical composition for the prevention or treatment of kidney damage. This invention focuses on a kidney inflammation inhibitor and includes D-alanine or a derivative thereof. The composition aims to provide a solution for kidney disease prevention and improvement. Another notable patent is a kidney disease prognosis prediction method and system. This invention utilizes the analysis of D- and L-amino acids from blood samples to predict the prognosis for kidney disease, enhancing the ability to assess patient outcomes.

Career Highlights

Throughout his career, Kenji Hamase has worked with reputable organizations, including Shiseido Company, Limited and Kyushu University. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Masashi Mita and Yurika Miyoshi. Their collaborative efforts have further advanced research in the field of kidney health.

Conclusion

Kenji Hamase's contributions to kidney disease treatment through his innovative patents highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in kidney health and prognosis prediction.